© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
July 29th 2022
A panel of medical experts open a discussion surrounding heart failure and its prevalence in health care.
Jim Januzzi, MD, outlines a multitude of drug treatment options for heart failure revolving around patient ejection fraction (EF) status.
August 5th 2022
Ryan Haumschild, PharmD, MS, MBA, leads a conversation regarding value statements and their alignment with cost-effective care.
Panelists discuss treatment for heart failure in the presence of comorbid disease impacting payer considerations.
August 12th 2022
Drs Uppal and Januzzi explore benefits of population health programs for treating chronic conditions associated with heart failure.
Dr Haumschild leads an overview of updates to ACC guidelines directing treatment of patients with heart failure.